A pragmatic and cost-effective strategy of a combination therapy of interferon alpha-2b and ribavirin for the treatment of chronic hepatitis C. (Q34276306)
Jump to navigation
Jump to search
scientific article published in May 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A pragmatic and cost-effective strategy of a combination therapy of interferon alpha-2b and ribavirin for the treatment of chronic hepatitis C. |
scientific article published in May 2001 |
Statements
A pragmatic and cost-effective strategy of a combination therapy of interferon alpha-2b and ribavirin for the treatment of chronic hepatitis C (English)
M Sagmeister
J B Wong